Conversa Health, a virtual care and triage platform, expanded its Series B financing to $20 million.
Investors include Builders VC, Northwell Health, UH Ventures, P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health, and Nassau Street Ventures.
The Series B round, first announced at $12 million in June 2020, was co-led by Builders VC and Northwell Ventures, the corporate venture arm of Northwell Health.
With the closing of the Series B round, Conversa has raised $34 million to date. The company plans to use the new additional Series B funds to scale its technology platform, expand its library of automated virtual care digital pathways, and fuel growth with new and existing customers.
Conversa enables health systems to virtually engage, monitor, and manage patients more for acute discharge, chronic care, perioperative, oncology, prevention, wellness, and more. According to the company, its automated care platform engages patients at high frequency and scale while triaging to higher-touch/cost care venues when necessary, optimizing and improving telehealth e-visits, phone calls, and in-person consults.
“In the future, much of healthcare will be done remotely. Conversa’s automated platform helps care teams practice at the top of their license to deliver high-quality care at much lower cost,” said Conversa CEO Murray Brozinsky. Our technology continually analyzes health data, using the resulting ‘signals’ to navigate patients along personalized journeys down evidence-based pathways. This data-plus-behavioral science approach maximizes engagement and drives positive behaviors while reducing the variability of care.”
In 2020, Telemedicine companies raised $4.3 billion, a 139% increase YoY, compared to $1.8 billion in 2019, according to the latest Mercom Digital Health Funding & M&A report. Recently, Curai Health, an AI-powered virtual care startup offering chat-based primary care services, announced a $27.5 million Series B funding round led by Morningside Ventures.